Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

摘要

Background Discontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a long period of relapse freedom is frequently considered, but data on post-cessation disease course are lacking.